Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

After reviewing years of data from its clinic, one institution discovered that issues with implant data integrity frequently put patients at risk. 

According to new survey data, nonadherence is not for lack of concern about the disease—75% of the women surveyed reported being concerned about their breast health.  

This week, the American Cancer Society’s annual Breast Cancer Statistics report revealed several eye-opening figures.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

The large language model can also outperform other human providers, radiologists included, new study shows.

It allows providers to quantify changes in tumor size throughout patients’ treatment in real-time, providing early indications of efficacy and enabling adjustments as needed.

New research suggests that treatment regimens can be nearly halved without increasing the risk of recurrence or complications further down the road.